Q3 2023 13F Holders as of 30 Sep 2023
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
89,532,454
-
Share change
-
-4,045,581
-
Total reported value
-
$272,176,868
-
Put/Call ratio
-
94%
-
Price per share
-
$3.04
-
Number of holders
-
165
-
Value change
-
-$12,872,464
-
Number of buys
-
68
-
Number of sells
-
66
Institutional Holders of BLUEBIRD BIO INC - COM (BLUE) as of Q3 2023
As of 30 Sep 2023,
BLUEBIRD BIO INC - COM (BLUE) was held by
165 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
89,532,454 shares.
The largest 10 holders included
STATE STREET CORP, BlackRock Inc., PFM Health Sciences, LP, VANGUARD GROUP INC, Pictet Asset Management Holding SA, Granahan Investment Management, LLC, TANG CAPITAL MANAGEMENT LLC, Woodline Partners LP, BAKER BROS. ADVISORS LP, and AMERIPRISE FINANCIAL INC.
This page lists
165
institutional shareholders reporting positions in this security
for the Q3 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.